New Study Says Tonalin CLA Delivers Health Benefits for Mild Asthmatics

September 16, 2010

In the first published study of its kind, Tonalin CLA was found to improve airway hyperreactivity in overweight mild asthmatics accompanied by a significant improvement in their tolerance for strenuous exercise.

In the first published study of its kind, Tonalin CLA was found to improve airway hyperreactivity in overweight mild asthmatics accompanied by a significant improvement in their tolerance for strenuous exercise.

Adults taking Tonalin CLA also reduced their body weight and BMI by 2 kg (4.4 lbs) and 0.5 kg/m2 over time, which was associated with a metabolically favorable change in adipokine concentrations. The reductions observed in the CLA group were significantly different from the placebo group, confirming once again a beneficial impact of CLA on weight and body-fat management.

The prospective, randomized, double-blind, placebo-controlled intervention trial, published in the July edition of the Journal of Clinical & Experimental Allergy, was conducted by a team of researchers at the University of British Colombia, Vancouver, Canada. In the 12-week study, supplementation of Tonalin CLA was an adjunct to usual care in overweight asthmatics and was well tolerated. The 28 mildly asthmatic men and women were randomized to consume 4.5 g/daily of Tonalin CLA or a placebo.

In their discussion, researchers stated that CLA could be beneficial for asthma treatment for a number of reasons. Diets rich in milk fat, an important source of CLA, have been associated with a lower risk of asthma symptoms 2,3. Biological activities of CLA including the regulation of inflammation 4-6 and reduction of body fat mass 7 are described as consistent with the potential benefits in asthma.

Press release by Cognis